Increasing high-density lipoprotein cholesterol through cholesteryl ester transfer protein inhibition: A next step in the fight against cardiovascular disease?

Current Drug Targets - Cardiovascular and Haematological Disorders

Volumn 5, Issue 6, 2005, Pages 481-488

  Van der Steeg, W A ^a   El Harchaoui, K ^a   Kuivenhoven, J A ^a   Kastelein, J J P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Atherosclerosis; Cholesteryl ester transfer protein (CETP); High density lipoprotein (HDL c); JTT 705; Torcetrapib

Indexed keywords

2 METHYLPROPANETHIOIC ACID S [2 [1 (2 ETHYLBUTYL)CYCLOHEXYLCARBOXAMIDO]PHENYL] ESTER; ATORVASTATIN; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRAVASTATIN; TORCETRAPIB; TRIACYLGLYCEROL; CARRIER PROTEIN; CETP PROTEIN, HUMAN; GLYCOPROTEIN; QUINOLINE DERIVATIVE; THIOL DERIVATIVE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG DOSE REGIMEN; DYSLIPIDEMIA; HUMAN; IN VITRO STUDY; LIPID METABOLISM; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR; RISK REDUCTION; SIDE EFFECT; BIOLOGICAL MODEL; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY;

ATHEROSCLEROSIS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; GLYCOPROTEINS; HUMANS; MODELS, BIOLOGICAL; QUINOLINES; SULFHYDRYL COMPOUNDS;

EID: 29444432231     PISSN: 15680061     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800605774961997     Document Type: Review

References (62)

1. LaRosa, J.C., He, J., Vupputuri, S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA, 1999, 282, 2340-2346.
2. Gordon, T., Castelli, W.P., Hjortland, M.C., Kannel, W.B., Dawber, T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med., 1977, 62, 707-714.
3. Genest, J.J., McNamara, J.R., Salem, D.N., Schaefer, E.J. Prevalence of risk factors in men with premature coronary artery disease. Am. J. Cardiol., 1991, 67, 1185-1189.
4. Robins, S.J., Collins, D., Wittes, J.T., Papademetriou, V., Deedwania, P.C., Schaefer, E.J., McNamara, J.R., Kashyap, M.L., Hershman, J.M., Wexler, L.F., Rubins, H.B. Relation of gemfibrozil treatment and lipid levels with major coronary events: VAHIT: a randomized controlled trial. JAMA, 2001, 285, 1585-1591.
5. Taylor, A.J., Sullenberger, L.E., Lee, H.J., Lee, J.K., Grace, K.A. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation, 2004, 110, 3512-3517.
6. Maeda, K., Noguchi, Y., Fukui, T. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. Prev. Med., 2003, 37, 283-290.
7. Toth, P.P. High-density lipoprotein and cardiovascular risk. Circulation, 2004, 109, 1809-1812.
8. Birjmohun, R.S., Hutten, B.A., Kastelein, J.J., Stroes, E.S. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. J. Am. Coll. Cardiol., 2005, 45, 185-197.
9. Birjmohun, R.S., Hutten, B.A., Kastelein, J.J., Stroes, E.S. Increasing HDL cholesterol with extended-release nicotinic acid: from promise to practice. Neth. J. Med., 2004, 62, 229-234.
10. Navab, M., Anantharamaiah, G.M., Reddy, S.T., Hama, S., Hough, G., Grijalva, V.R., Yu, N., Ansell, B.J., Datta, G., Garber, D.W., Fogelman, A.M. Apolipoprotein A-I Mimetic Peptides. Arterioscler. Thromb. Vasc. Biol., 2005.
11. Nissen, S.E., Tsunoda, T., Tuzcu, E.M., Schoenhagen, P., Cooper, C.J., Yasin, M., Eaton, G.M., Lauer, M.A., Sheldon, W.S., Grines, C.L., Halpern, S., Crowe, T., Blankenship, J.C., Kerensky, R. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA, 2003, 290, 2292-2300.
12. Nichols, A.V., Rehnborg, C.S., Lindgren, F.T., Wills, R.D. Effects of oil ingestion on lipoprotein fatty acids in man. J. Lipid Res., 1962, 3, 320-326.
13. Ashworth, L.A., Green, C. The uptake of lipids by human alpha-lipoprotein. Biochim. Biophys. Acta, 1963, 70, 68-74.
14. Nichols, A.V., Smith, L. Effect of very low-density lipoproteins on lipid transfer in incubated serum. J. Lipid Res., 1965, 58, 206-210.
15. Pattnaik, N.M., Montes, A., Hughes, L.B., Zilversmit, D.B. Cholesteryl ester exchange protein in human plasma isolation and characterization. Biochim. Biophys. Acta, 1978, 530, 428-438.
16. Jarnagin, A.S., Kohr, W., Fielding, C. Isolation and specificity of a Mr 74,000 cholesteryl ester transfer protein from human plasma. Proc. Natl. Acad. Sci. USA, 1987, 84, 1854-1857.
17. Drayna, D., Jarnagin, A.S., McLean, J., Henzel, W., Kohr, W., Fielding, C., Lawn, R. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature, 1987, 327, 632-634.
18. Lusis, A.J., Zollman, S., Sparkes, R.S., Klisak, I., Mohandas, T., Drayna, D., Lawn, R.M. Assignment of the human gene for cholesteryl ester transfer protein to chromosome 16q12-16q21. Genomics, 1987, 1, 232-235.
19. Agellon, L.B., Quinet, E.M., Gillette, T.G., Drayna, D.T., Brown, M.L., Tall, A.R. Organization of the human cholesteryl ester transfer protein gene. Biochemistry, 1990, 29, 1372-1376.
20. Jiang, X.C., Moulin, P., Quinet, E., Goldberg, I.J., Yacoub, L.K., Agellon, L.B., Compton, D., Schnitzer-Polokoff, R., Tall, A.R. Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J. Biol. Chem., 1991, 266, 4631-4639.
21. Tall, A.R. Plasma lipid transfer proteins. J. Lipid Res., 1986, 27, 361-367.
22. Koizumi, J., Mabuchi, H., Yoshimura, A., Michishita, I., Takeda, M., Itoh, H., Sakai, Y., Sakai, T., Ueda, K., Takeda, R. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. Atherosclerosis, 1985, 58, 175-186.
23. Brown, M.L., Inazu, A., Hesler, C.B., Agellon, L.B., Mann, C., Whitlock, M.E., Marcel, Y.L., Milne, R.W., Koizumi, J., Mabuchi, H. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature, 1989, 342, 448-451.
24. Takahashi, K., Jiang, X.C., Sakai, N., Yamashita, S., Hirano, K., Bujo, H., Yamazaki, H., Kusunoki, J., Miura, T., Kussie, P. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J. Clin. Invest, 1993, 92, 2060-2064.
25. Inazu, A., Jiang, X.C., Haraki, T., Yagi, K., Kamon, N., Koizumi, J., Mabuchi, H., Takeda, R., Takata, K., Moriyama, Y. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J. Clin. Invest., 1994, 94, 1872-1882.
26. Hovingh, G.K., de Groot, E., van der, S.W., Boekholdt, S.M., Hutten, B.A., Kuivenhoven, J.A., Kastelein, J.J. Inherited disorders of HDL metabolism and atherosclerosis. Curr. Opin. Lipidol., 2005, 16, 139-145.
27. The, E.M., Dolphin, P.J., Breckenridge, W.C., Tan, M.H. Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America. J. Lipid Res., 1998, 39, 442-456.
28. Nagano, M., Yamashita, S., Hirano, K., Takano, M., Maruyama, T., Ishihara, M., Sagehashi, Y., Kujiraoka, T., Tanaka, K., Hattori, H., Sakai, N., Nakajima, N., Egashira, T., Matsuzawa, Y. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese. J. Atheroscler. Thromb., 2004, 11, 110-121.
29. Ikewaki, K., Rader, D.J., Sakamoto, T., Nishiwaki, M., Wakimoto, N., Schaefer, J.R., Ishikawa, T., Fairwell, T., Zech, L.A., Nakamura, H. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency. J. Clin. Invest, 1993, 92, 1650-1658.
30. Yamashita, S., Hui, D.Y., Wetterau, J.R., Sprecher, D.L., Harmony, J.A., Sakai, N., Matsuzawa, Y., Tarui, S. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition. Metabolism, 1991, 40, 756-763.
31. Arai, T., Tsukada, T., Murase, T., Matsumoto, K. Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency. Clin. Chim. Acta, 2000, 301, 103-117.
32. Asztalos, B.F., Horvath, K.V., Kajinami, K., Nartsupha, C., Cox, C.E., Batista, M., Schaefer, E.J., Inazu, A., Mabuchi, H. Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency. J. Lipid Res., 2004, 45, 448-455.
33. Sakai, N., Matsuzawa, Y., Hirano, K., Yamashita, S., Nozaki, S., Ueyama, Y., Kubo, M., Tarui, S. Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency. Arterioscler. Thromb., 1991, 11, 71-79.
34. Inazu, A., Brown, M.L., Hesler, C.B., Agellon, L.B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., Tall, A.R. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N. Engl. J. Med., 1990, 323, 1234-1238.
35. Moriyama, Y., Okamura, T., Inazu, A., Doi, M., Iso, H., Mouri, Y., Ishikawa, Y., Suzuki, H., Iida, M., Koizumi, J., Mabuchi, H., Komachi, Y. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. Prev. Med., 1998, 27, 659-667.
36. Hirano, K., Yamashita, S., Nakajima, N., Arai, T., Maruyama, T., Yoshida, Y., Ishigami, M., Sakai, N., Kameda-Takemura, K., Matsuzawa, Y. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler. Thromb. Vasc. Biol., 1997, 17, 1053-1059.
37. Zhong, S., Sharp, D.S., Grove, J.S., Bruce, C., Yano, K., Curb, J.D., Tall, A.R. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin. Invest., 1996, 97, 2917-2923.
38. Curb, J.D., Abbott, R.D., Rodriguez, B.L., Masaki, K., Chen, R., Sharp, D.S., Tall, A.R. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J. Lipid Res., 2004, 45, 948-953.
39. Boekholdt, S.M., Kuivenhoven, J.A., Wareham, N.J., Peters R.J., Jukema, J.W., Luben, R., Bingham, S.A., Day, N.E., Kastelein, J.J., Khaw, K.T. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study. Circulation, 2004, 110, 1418-1423.
40. Rittershaus, C.W., Miller, D.P., Thomas, L.J., Picard, M.D., Honan, C.M., Emmett, C.D., Pettey, C.L., Adari, H., Hammond, R.A., Beattie, D.T., Callow, A.D., Marsh, H.C., Ryan, U.S. Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2000, 20, 2106-2112.
41. Davidson, M.H., Maki, K., Umporowicz, D., Wheeler, A., Rittershaus, C., Ryan, U. The safety and immunogenicity of a CETP vaccine in healthy adults. Atherosclerosis, 2003, 169, 113-120.
42. De Grooth, G.J., Kuivenhoven, J.A., Stalenhoef, A.F., de Graaf, J., Zwinderman, A.H., Posma, J.L., van Tol, A., Kastelein, J.J. Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study. Circulation, 2002, 105, 2159-2165.
43. Kuivenhoven, J.A., De Grooth, G.J., Kawamura, H., Klerkx, A.H., Wilhelm, F., Trip, M.D., Kastelein, J.J. Effectiveness of Inhibition of Cholesteryl Ester Transfer Protein by JTT-705 in Combination With Pravastatin in Type II Dyslipidemia. Am. J. Cardiol., 2005, 95, 1085-1088.
44. Clark, R.W., Sutfin, T.A., Ruggeri, R.B., Willauer, A.T., Sugarman, E.D., Magnus-Aryitey, G., Cosgrove, P.G., Sand, T.M., Wester, R.T., Williams, J.A., Perlman, M.E., Bamberger, M.J. Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib. Arterioscler. Thromb. Vasc. Biol., 2004, 24, 490-497.
45. Brousseau, M.E., Schaefer, E.J., Wolfe, M.L., Bloedon, L.T., Digenio, A.G., Clark, R.W., Mancuso, J.P., Rader, D.J. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N. Engl. J. Med., 2004, 350, 1505-1515.
46. Glomset, J.A. The plasma lecithins:cholesterol acyltransferase reaction. J. Lipid Res., 1968, 9, 155-167.
47. von Eckardstein, A., Nofer, J.R., Assmann, G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol., 2001, 21, 13-27.
48. Ishigami, M., Yamashita, S., Sakai, N., Arai, T., Hirano, K., Hiraoka, H., Kameda-Takemura, K., Matsuzawa, Y. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins. J. Biochem. (Tokyo), 1994, 116, 257-262.
49. Wang, N., Lan, D., Chen, W., Matsuura, F., Tall, A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. USA, 2004, 101, 9774-9779.
50. Rigotti, A., Trigatti, B.L., Penman, M., Rayburn, H., Herz, J., Krieger, M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. USA, 1997, 94, 12610-12615.
51. Connelly, M.A., Williams, D.L. Scavenger receptor B.I: a scavenger receptor with a mission to transport high density lipoprotein lipids. Curr. Opin. Lipidol., 2004, 15, 287-295.
52. Thuahnai, S.T., Lund-Katz, S., Dhanasekaran, P., Llera-Moya, M., Connelly, M.A., Williams, D.L., Rothblat, G.H., Phillips, M.C. Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol. Influence of high density lipoprotein size and structure. J. Biol. Chem., 2004, 279, 12448-12455.
53. Trigatti, B.L., Krieger, M., Rigotti, A. Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2003, 23, 1732-1738.
54. Brousseau, M.E., Diffenderfer, M.R., Millar, J.S., Nartsupha, C., Asztalos, B.F., Welty, F.K., Wolfe, M.L., Rudling, M., Bjorkhem, I., Angelin, B., Mancuso, J.P., Digenio, A.G., Rader, D.J., Schaefer, E.J.. Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion. Arterioscler. Thromb. Vasc. Biol., 2005.
55. Schwartz, C.C., VandenBroek, J.M., Cooper, P.S. Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans. J. Lipid Res., 2004, 45, 1594-1607.
56. Assmann, G., Gotto, A.M. Jr. HDL cholesterol and protective factors in atherosclerosis. Circulation, 2004, 109, III8-14.
57. Navab, M., Ananthramaiah, G.M., Reddy, S.T., Van Lenten, B.J., Ansell, B.J., Fonarow, G.C., Vahabzadeh, K., Hama, S., Hough, G., Kamranpour, N., Berliner, J.A., Lusis, A.J., Fogelman, A.M. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J. Lipid Res., 2004, 45, 993-1007.
58. Ridker, P.M., Cannon, C.P., Morrow, D., Rifai, N., Rose, L.M., McCabe, C.H., Pfeffer, M.A., Braunwald, E. C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med., 2005, 352, 20-28.
59. Guerin, M., Le Goff, W., Lassel, T.S., van Tol, A., Steiner, G., Chapman, M.J. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia. Arlerioscler. Thromb. Vasc. Biol., 2001, 21, 282-288.
60. Elchebly M, Porokhov B, Pulcini T, Berthezene F, Ponsin G. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM). Atherosclerosis, 1996, 123, 93-101.
61. Hayek, T., Masucci-Magoulas, L., Jiang, X., Walsh, A., Rubin, E., Breslow, J.L., Tall, A.R. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J. Clin. Invest., 1995, 96, 2071-2074.
62. Barter, P.J., Brewer, H.B. Jr., Chapman, M.J., Hennekens, C.H., Rader, D.J., Tall, A.R. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2003, 23, 160-167.